This compound is a pharmaceutical intermediate used in the production of reference standards for Afatinib-related impurities. It features a complex aromatic structure with multiple functional groups, including carboxylic acid and amide moieties, and is supplied for research and manufacturing purposes.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 2413212-27-6
N1,N2-Bis(4-((3-chloro-4-fluorophenyl)amino)-7-(((S)-tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)oxalamide
Pharmaceutical intermediate for Afatinib impurities
2306254-34-0free base
pharmaceutical intermediate
(4,5,6,7-Tetrahydropyrazolo[1,5-a]pyrazin-2-yl)methanol dihydrochloride
Pharmaceutical intermediate
MC-Gly-Gly-Phe-Gly
pharmaceutical intermediate for antibody-drug conjugate
N-(4-((3-Chloro-4-fluorophenyl)amino)-7-(((S)-tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-3,4-bis(dimethylamino)butanamide
Pharmaceutical reference impurity standard
2-(3-chloro-N-[6-[[(E)-4-(dimethylamino)but-2-enoyl]amino]-7-[(3S)-oxolan-3-yl]oxyquinazolin-4-yl]-4-fluoroanilino)propanedioic acid
USVQENIYOMXKKQ-CWDCEQMOSA-N
CN(C)C/C=C/C(=O)NC1=C(C=C2C(=C1)C(=NC=N2)N(C3=CC(=C(C=C3)F)Cl)C(C(=O)O)C(=O)O)O[C@H]4CCOC4
—